ATRIUM THERAPEUTICS INC (RNA) — institutional ownership

155 funds reported holding ATRIUM THERAPEUTICS INC in their latest 13F filings, worth $205M in total (CUSIP 04965N104).

Largest holders

1. Sessa Capital IM, L.P. — $20.2M
2. PRICE T ROWE ASSOCIATES INC /MD/ — $19.8M
3. BlackRock, Inc. (BLK) — $19.5M
4. SUSQUEHANNA INTERNATIONAL GROUP, LLP — $11.3M
5. VANGUARD CAPITAL MANAGEMENT LLC — $9.83M
6. CRCM LP — $8.63M
7. TIG Advisors, LLC — $7.55M
8. GEODE CAPITAL MANAGEMENT, LLC — $5.21M
9. TWO SIGMA INVESTMENTS, LP — $4.65M
10. GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $4.17M

Famous investors holding it

• Two Sigma portfolio (Two Sigma Investments)
• Izzy Englander portfolio (Millennium Management)
• Ken Griffin portfolio (Citadel Advisors)
• Renaissance Technologies portfolio (Renaissance Technologies)

Insider buying and selling at ATRIUM THERAPEUTICS INC

Who owns the most RNA stock?

The largest institutional holders in the latest 13F filings are Sessa Capital IM, L.P. ($20.2M), PRICE T ROWE ASSOCIATES INC /MD/ ($19.8M), BlackRock, Inc. (BLK) ($19.5M).

How many funds own RNA?

155 funds reported holding it, worth $205M in total.